Drug that binds bile acids in the intestine and prevents their return to liver the enterohepatic circulation is?
First, the core concept here is about bile acid sequestrants. These drugs work by binding bile acids in the gut, which are normally reabsorbed in the ileum and returned to the liver through the enterohepatic circulation. By blocking this, the liver has to use more cholesterol to make new bile acids, which lowers LDL cholesterol.
The correct answer is likely Cholestyramine, which is a well-known bile acid sequestrant. Other options might include drugs like Ezetimibe, which works differently by inhibiting the Niemann-Pick C1-Like 1 (NPC1L1) transporter in the small intestine, reducing cholesterol absorption. Statins inhibit HMG-CoA reductase, another pathway. Colesevelam is another sequestrant but maybe not as commonly tested.
For the wrong options: Option A could be Ezetimibe, which doesn't bind bile acids. Option B might be a statin like Atorvastatin. Option C could be something like Niacin, which affects lipid metabolism but doesn't bind bile acids. Option D might be another statin or a different mechanism.
Clinical pearl: Remember that bile acid sequestrants are used for hypercholesterolemia, especially when combined with statins. They can cause constipation and interfere with absorption of other medications, so timing is important.
Need to make sure the explanation is concise, covers all sections, and stays within the character limit. Also, check that each section is properly formatted with bold labels and the correct answer at the end.
**Core Concept**
The question tests knowledge of **bile acid sequestrants**, a class of drugs that bind bile acids in the gastrointestinal tract, preventing their reabsorption via the **enterohepatic circulation**. This mechanism reduces hepatic cholesterol stores, indirectly lowering LDL cholesterol levels.
**Why the Correct Answer is Right**
**Cholestyramine** is a **bile acid sequestrant** that binds bile acids (e.g., cholic acid, chenodeoxycholic acid) in the ileum and colon. By blocking their reabsorption, it forces the liver to synthesize more bile acids from cholesterol, depleting hepatic cholesterol stores. This upregulates hepatic LDL receptors, increasing LDL clearance from the blood. It is used to treat hypercholesterolemia and pruritus in cholestatic liver disease.
**Why Each Wrong Option is Incorrect**
**Option A: Ezetimibe** – Inhibits **NPC1L1**, reducing intestinal cholesterol absorption, not bile acid binding.
**Option B: Atorvastatin** – Inhibits **HMG-CoA reductase**, a key enzyme in cholesterol synthesis, unrelated to bile acid sequestration.
**Option C: Niacin** – Reduces hepatic VLDL synthesis and increases HDL; no direct effect on bile acid reabsorption.
**Option D: Colesevelam** – Also a bile